Protein profile
KP13_05584
putative pyruvate-flavodoxin oxidoreductase
Genome: KpKP13
Overview
Basic information about this protein and its source genome.
- Accession
- KP13_05584
- Gene
- AHE44876.1
- Status
- annotated
- Amino acids
- 1175
- Structure source
- AlphaFold + ColabFold
Target profile
Computed evidence for target prioritization.
- Human off-target
- No hit
- Human identity (%)
- 0.0
- Gut microbiome off-target
- hit
- Essential (DEG)
- N
- DEG identity (%)
- 0.0
- Localization
- CytoplasmicMembrane
- ColabFold pLDDT
- 95.06
Selected Druggability evidence
AlphaFold / UniProt modelSelected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
Functional Annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Enzyme Commission (EC)
1Gene Ontology (GO)
8- GO:0030976 Binding to thiamine pyrophosphate, the diphosphoric ester of thiamine. Acts as a coenzyme of several (de)carboxylases, transketolases, and alpha-oxoacid dehydrogenases.
- GO:0022900 A process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors.
- GO:0016903 Catalysis of an oxidation-reduction (redox) reaction in which an aldehyde or ketone (oxo) group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
- GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
- GO:0005506 Binding to an iron (Fe) ion.
- GO:0003824 Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
- GO:0051539 Binding to a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.
- GO:0006979 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
Sequence Features
Domain/signature hits from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 736 | 765 | ProSiteProfiles | PS51379 | 4Fe-4S ferredoxin-type iron-sulfur binding domain profile. |
| 736 | 765 | InterPro | IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain |
| 631 | 668 | Gene3D | G3DSA:4.10.780.10 | - |
| 631 | 668 | InterPro | IPR037112 | Pyruvate-flavodoxin oxidoreductase, EKR domain superfamily |
| 669 | 791 | Gene3D | G3DSA:3.30.70.20 | - |
| 680 | 709 | ProSiteProfiles | PS51379 | 4Fe-4S ferredoxin-type iron-sulfur binding domain profile. |
| 680 | 709 | InterPro | IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain |
| 6 | 169 | CDD | cd07034 | TPP_PYR_PFOR_IOR-alpha_like |
| 6 | 169 | InterPro | IPR002880 | Pyruvate flavodoxin/ferredoxin oxidoreductase, pyrimidine binding domain |
| 2 | 254 | SUPERFAMILY | SSF52518 | Thiamin diphosphate-binding fold (THDP-binding) |
| 2 | 254 | InterPro | IPR029061 | Thiamin diphosphate-binding fold |
| 665 | 838 | SUPERFAMILY | SSF54862 | 4Fe-4S ferredoxins |
| 1 | 1164 | PANTHER | PTHR32154 | PYRUVATE-FLAVODOXIN OXIDOREDUCTASE-RELATED |
| 255 | 414 | Gene3D | G3DSA:3.40.50.920 | - |
| 255 | 414 | InterPro | IPR009014 | Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II |
| 419 | 668 | SUPERFAMILY | SSF53323 | Pyruvate-ferredoxin oxidoreductase, PFOR, domain III |
| 419 | 668 | InterPro | IPR002869 | Pyruvate-flavodoxin oxidoreductase, central domain |
| 1 | 1165 | NCBIfam | TIGR02176 | pyruvate:ferredoxin (flavodoxin) oxidoreductase |
| 1 | 1165 | InterPro | IPR011895 | Pyruvate-flavodoxin oxidoreductase |
| 1 | 1174 | PIRSF | PIRSF000159 | NifJ |
| 1 | 1174 | InterPro | IPR011895 | Pyruvate-flavodoxin oxidoreductase |
| 417 | 623 | Gene3D | G3DSA:3.40.920.10 | - |
| 417 | 623 | InterPro | IPR002869 | Pyruvate-flavodoxin oxidoreductase, central domain |
| 1 | 254 | Gene3D | G3DSA:3.40.50.970 | - |
| 689 | 757 | Pfam | PF12838 | 4Fe-4S dicluster domain |
| 689 | 757 | InterPro | IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain |
| 1 | 254 | FunFam | G3DSA:3.40.50.970:FF:000012 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 426 | 610 | Pfam | PF01558 | Pyruvate ferredoxin/flavodoxin oxidoreductase |
| 426 | 610 | InterPro | IPR019752 | Pyruvate/ketoisovalerate oxidoreductase, catalytic domain |
| 811 | 1166 | CDD | cd03377 | TPP_PFOR_PNO |
| 794 | 1167 | Gene3D | G3DSA:3.40.50.970 | - |
| 669 | 791 | FunFam | G3DSA:3.30.70.20:FF:000022 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 794 | 1166 | SUPERFAMILY | SSF52518 | Thiamin diphosphate-binding fold (THDP-binding) |
| 794 | 1166 | InterPro | IPR029061 | Thiamin diphosphate-binding fold |
| 255 | 411 | SUPERFAMILY | SSF52922 | TK C-terminal domain-like |
| 255 | 411 | InterPro | IPR009014 | Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II |
| 622 | 679 | SMART | SM00890 | EKR_2 |
| 622 | 679 | InterPro | IPR019456 | Pyruvate-flavodoxin oxidoreductase, EKR domain |
| 265 | 347 | Pfam | PF17147 | Pyruvate:ferredoxin oxidoreductase core domain II |
| 265 | 347 | InterPro | IPR033412 | Pyruvate:ferredoxin oxidoreductase, core domain II |
| 13 | 243 | Pfam | PF01855 | Pyruvate flavodoxin/ferredoxin oxidoreductase, thiamine diP-bdg |
| 13 | 243 | InterPro | IPR002880 | Pyruvate flavodoxin/ferredoxin oxidoreductase, pyrimidine binding domain |
| 255 | 413 | FunFam | G3DSA:3.40.50.920:FF:000007 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 631 | 668 | FunFam | G3DSA:4.10.780.10:FF:000001 | Probable pyruvate-flavodoxin oxidoreductase |
| 626 | 678 | Pfam | PF10371 | Domain of unknown function |
| 626 | 678 | InterPro | IPR019456 | Pyruvate-flavodoxin oxidoreductase, EKR domain |
| 745 | 756 | ProSitePatterns | PS00198 | 4Fe-4S ferredoxin-type iron-sulfur binding region signature. |
| 745 | 756 | InterPro | IPR017900 | 4Fe-4S ferredoxin, iron-sulphur binding, conserved site |
| 794 | 1167 | FunFam | G3DSA:3.40.50.970:FF:000047 | Probable pyruvate-flavodoxin oxidoreductase |
| 416 | 626 | FunFam | G3DSA:3.40.920.10:FF:000001 | Pyruvate:ferredoxin (Flavodoxin) oxidoreductase |
| 936 | 1066 | Pfam | PF02775 | Thiamine pyrophosphate enzyme, C-terminal TPP binding domain |
| 936 | 1066 | InterPro | IPR011766 | Thiamine pyrophosphate enzyme, TPP-binding |
3D Structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.
Loading 3D structure...
Structural evidence
0 + 2Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold
AF_A0A0H3GSL1
|
AlphaFold | — | — | full sequence | — | Viewing |
|
ColabFold
KP13_05584
|
ColabFold | — | — | full sequence | — | Loaded |
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 1 | 0.964 | ||||||
| 78 | 0.361 | ||||||
| 5 | 0.205 |
Pockets (P2RANK)
Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).
| P2RANK | Sticks | Spheres | Surfaces | Score | Probability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|---|
| 1 | 18.61 | 0.826 | ||||||
| 2 | 10.75 | 0.577 | ||||||
| 3 | 5.68 | 0.275 | ||||||
| 4 | 5.5 | 0.263 | ||||||
| 5 | 5.45 | 0.259 |
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 13 | 0.952 |
Pockets (P2RANK)
Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).
| P2RANK | Sticks | Spheres | Surfaces | Score | Probability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|---|
| 1 | 15.83 | 0.763 | ||||||
| 2 | 9.67 | 0.52 | ||||||
| 3 | 8.25 | 0.439 | ||||||
| 4 | 7.38 | 0.386 | ||||||
| 5 | 7.06 | 0.366 |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| 5SR | Q2RI41 | 468.3 Da LogP -0.09 TPSA 209.1 | ✓ Ro5 | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)C(=O)O)CCOP(=O)(O)OP…
|
|
| CO2 | P94692 | 44.0 Da LogP -0.58 TPSA 34.1 | ✓ Ro5 | ✓ Clean |
C(=O)=O
|
|
| HTL | P94692 | 467.4 Da LogP 1.04 TPSA 186.0 | ✓ Ro5 | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)C(=O)C)CCO[P@@](=O)(…
|
|
| O2T | Q2RI41 | 514.3 Da LogP -1.57 TPSA 249.6 | 3 viol. | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)C(C(=O)O)(O)O)CCOP(=…
|
|
| PYR | P94692 | 88.1 Da LogP -0.34 TPSA 54.4 | ✓ Ro5 | ✓ Clean |
CC(=O)C(=O)O
|
|
| TDL | Q2RMD6 | 513.4 Da LogP 0.13 TPSA 226.5 | 2 viol. | ✓ Clean |
Cc1c(sc([n+]1Cc2cnc(nc2N)C)[C@](C)(C(=O)O)O)CCO…
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
| Ligand | Tanimoto | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|
| ZINC8215517 | 0.656 | 425.3 Da LogP 0.84 TPSA 169.0 | ✓ Ro5 | ✓ Clean |
Cc1ncc(C[n+]2csc(CCO[P@@](=O)(O)OP(=O)(O)O)c2C)…
|
| ZINC1532839 | 0.522 | 345.3 Da LogP 0.72 TPSA 122.4 | ✓ Ro5 | ✓ Clean |
Cc1ncc(C[n+]2csc(CCOP(=O)(O)O)c2C)c(N)n1
|
| ZINC13540298 | 0.507 | 440.3 Da LogP 0.72 TPSA 187.1 | ✓ Ro5 | ✓ Clean |
Cc1ncc(Cn2c(C)c(CCO[P@@](=O)(O)OP(=O)(O)O)sc2=O…
|
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.